Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2964368rdf:typepubmed:Citationlld:pubmed
pubmed-article:2964368lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:2964368lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:2964368lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:2964368pubmed:issue3lld:pubmed
pubmed-article:2964368pubmed:dateCreated1988-4-11lld:pubmed
pubmed-article:2964368pubmed:abstractTextUsing membrane preparations of the interferon receptor, prepared from cells of the Burkitt line, Daudi, we have examined the binding of three human recombinant alpha-interferons. 1. We discovered a binding titration of the interferons IFN-alpha A and IFN-alpha D in the pH range 6-9. Receptor binding, negligible at pH 6, rises to a maximum close to pH 9. We have shown that binding of IFN-alpha A at basic pH is to the same receptors as at neutrality and that IFN-receptor complexes extracted with digitonin are more stable at basic pH than they are at neutrality. 2. The recombinant interferon, IFN-alpha B, shows little change of binding in the pH range 6-9. At its basic optimum the binding of IFN-alpha A approaches that of IFN-alpha B, while at neutral pH the binding of IFN-alpha A is 3-4 times less. This difference at neutral pH is seen on intact cells as well as on membrane preparations. The specific activity of IFN-alpha B is close to that of IFN-alpha A, both of which are 10-20 times more active than IFN-alpha D; and the binding titration is, therefore, independent of the initial binding affinities. 3. Using hybrid IFNs constructed from the DNA sequences of alpha D and alpha B, we have isolated the sequence responsible for the binding titration to the segment comprising amino acids 61-92. Examination of these sequences reveals that Lys-84 is present in all the IFN-alpha except IFN-alpha B where it is replaced by Glu; and Tyr-90, present in most of the common IFN-alpha including alpha A and alpha D, is replaced by Asp in IFN-alpha B. Lys and Tyr would normally titrate in the pH range 6-9. We conclude that the binding titration is due to an electrostatic interaction and we propose that the interaction is between IFN-receptor complexes. The role of the interaction in the binding losses that accompany the antiproliferative effects of IFN is discussed.lld:pubmed
pubmed-article:2964368pubmed:languageenglld:pubmed
pubmed-article:2964368pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2964368pubmed:citationSubsetIMlld:pubmed
pubmed-article:2964368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2964368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2964368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2964368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2964368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2964368pubmed:statusMEDLINElld:pubmed
pubmed-article:2964368pubmed:monthFeblld:pubmed
pubmed-article:2964368pubmed:issn0014-2956lld:pubmed
pubmed-article:2964368pubmed:authorpubmed-author:LiJ CJClld:pubmed
pubmed-article:2964368pubmed:authorpubmed-author:BanduM TMTlld:pubmed
pubmed-article:2964368pubmed:authorpubmed-author:MogensenK EKElld:pubmed
pubmed-article:2964368pubmed:authorpubmed-author:GrütterMMlld:pubmed
pubmed-article:2964368pubmed:authorpubmed-author:UzeGGlld:pubmed
pubmed-article:2964368pubmed:issnTypePrintlld:pubmed
pubmed-article:2964368pubmed:day1lld:pubmed
pubmed-article:2964368pubmed:volume171lld:pubmed
pubmed-article:2964368pubmed:ownerNLMlld:pubmed
pubmed-article:2964368pubmed:authorsCompleteYlld:pubmed
pubmed-article:2964368pubmed:pagination683-91lld:pubmed
pubmed-article:2964368pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:meshHeadingpubmed-meshheading:2964368-...lld:pubmed
pubmed-article:2964368pubmed:year1988lld:pubmed
pubmed-article:2964368pubmed:articleTitleElectrostatic interactions in the cellular dynamics of the interferon-receptor complex.lld:pubmed
pubmed-article:2964368pubmed:affiliationLaboratoire d'Oncologie Virale, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.lld:pubmed
pubmed-article:2964368pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2964368pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed